Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Obamacare Enrollment Drops 1.2 M in Jan 2026, Sparking Calls for Overhaul
Enrollment in the Affordable Care Act fell by about 1.2 million in January 2026, the sharpest early‑year decline since the program’s inception. Premiums jumped an average 26% and subsidies evaporated, fueling political pressure to rewrite the law.
Achieve Life Sciences Presents 52‑Week Cytisinicline Safety Data Ahead of FDA Decision
Achieve Life Sciences disclosed 52‑week safety results from its ORCA‑OL trial of Cytisinicline, a nicotine‑dependence therapy, at the ATS 2026 meeting. The data reinforce long‑term tolerability as the company approaches a June 20, 2026 FDA PDUFA deadline for its New...
Early Birth Safer for Mother and Baby in High Blood Pressure Pregnancies, Researchers Find
A new Cochrane review of six randomized trials involving 3,491 women shows that planning delivery after 34 weeks for pregnancies complicated by hypertension cuts serious maternal complications by nearly 50% and may lower stillbirth risk by about 75%. The analysis...
Study Finds Substandard Bowel Cancer Care for People with Learning Disability
A University of Manchester and Christie NHS study of over 2 million UK patients found that people with learning disabilities face markedly poorer bowel‑cancer care. They develop the disease earlier, are less likely to receive stool tests, urgent referrals or endoscopy,...
Did a Boy’s Life-Saving Gene Therapy Cause His Brain Tumour?
A five‑year‑old who received adeno‑associated virus (AAV) gene therapy for a rare genetic disorder developed a brain tumor four years later. Genetic analysis traced the tumor to integration of the viral vector into the child’s genome, suggesting a causal link....
Colorado Supreme Court Orders Children's Hospital to Resume Gender-Affirming Care for Minors
The Colorado Supreme Court ruled 5‑2 that Children's Hospital Colorado must resume gender‑affirming treatments for minors, overturning the hospital’s January suspension prompted by a HHS investigation. The decision found the pause violated Colorado’s antidiscrimination law protecting gender identity and disability....
H-ISAC’s Englert Says Device Inventory and PHI Mapping Will Be the Heaviest Lifts When New HIPAA Drops
In this episode, Phil Englert, VP of Medical Device Security at Health‑ISAC, explains how the upcoming HIPAA security rule revisions will force healthcare organizations to undertake massive device inventories and map protected health information (PHI) flows across medical devices and...
INSULIN Acts Snags Support Of Four New Co-Sponsors
Four additional senators have joined the bipartisan INSULIN Act, bringing the total number of co‑sponsors to 19. The legislation seeks to extend Medicare’s $35 monthly out‑of‑pocket cap for insulin to the commercial insurance market. If enacted, the bill would standardize...
Health Care Is Facing a Moral Emergency, Argue Experts
Experts in The BMJ warn that modern healthcare faces a moral emergency as technical prowess outstrips the human, relational foundations of care. They argue that profit‑driven models and industrialized protocols leave patients feeling processed and staff experiencing moral distress, driving...
China's Health Care Use Has Not Fully Recovered After Zero-COVID Policy, with Rural Regions Lagging Most
A PLOS Medicine analysis led by Fred Hutch researchers found that China’s health‑care utilization remains below pre‑pandemic expectations two years after ending its Dynamic Zero‑COVID policy. Outpatient clinic visits are down 7% (about 1.2 billion fewer visits) and hospitalizations 13% (roughly...
CMS to Cap State Medicaid Payments to Save $775B: 7 Things to Know
The Centers for Medicare & Medicaid Services (CMS) has proposed a rule to cap state‑directed Medicaid payments and certain fee‑for‑service rates, aligning them with Medicare benchmarks. The agency estimates the limits will curb Medicaid spending by more than $775 billion over...
FDA Turnover Delays Rare Disease Drug Development, Experts Warn
Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development https://t.co/H3z7G2kQyc via @statnews
‘An Untenable Situation’: Providence to Wind Down Insurance Business
Providence Health Plan announced it will wind down most of its insurance operations starting in 2027, ending a 40‑year run as a regional payer and affecting roughly 440,000 members. The decision follows a $102 million net loss on $2.5 billion revenue in...
Enlil Forms Strategic Alliance with OVA Solutions to Solve Medtech’s Costliest Documentation Problem
Enlil, an AI‑driven development traceability platform, has partnered with OVA Solutions to eliminate the costly documentation gap that adds $100,000‑$200,000 and up to six months of delay to medtech projects. The alliance embeds real‑time requirements, risk and change management into...
PeaceHealth, Eugene Emergency Physicians Reach 3-Year Contract
PeaceHealth and Eugene Emergency Physicians (EEP) have reached a three‑year staffing agreement for PeaceHealth Sacred Heart Medical Center at RiverBend and PeaceHealth Cottage Grove Community Medical Center. The deal ends a legal battle that began when PeaceHealth sought to replace...
Judy Faulkner: Epic Doesn’t Stifle Competition
Epic Systems, the dominant electronic health‑record vendor, is defending its use of non‑compete agreements as essential trade‑secret protection, a stance reiterated by founder‑CEO Judy Faulkner in a live interview. The company recently prevailed in a lawsuit filed by Veeva Systems,...
Celebrate 80 Years of HFMA at AC26
The Healthcare Financial Management Association (HFMA) is celebrating its 80th anniversary at the AC26 Annual Conference, held June 7‑10, 2026 in National Harbor, Maryland. The flagship evening event runs Sunday, June 7 from 7:00‑9:00 p.m. ET in the Potomac Ballroom and is sponsored by...
IL-6 Blocker Shows Promise for Treating Depression
Would depression respond to an anti-inflammation drug (interleukin-6 blocker)? A small pilot, placebo-controlled randomized trial suggests this might be possible https://t.co/zKO76yvRAo https://t.co/e8K9YLEAQj
Kennedy Terminates USPSTF Leaders To ‘Avoid Uncertainty’
HHS Secretary Robert F. Kennedy Jr. dismissed the chair and deputy chair of the U.S. Preventive Services Task Force (USPSTF) after a year of repeatedly canceling the panel’s meetings. The move deepens uncertainty about the task force’s ability to issue...
The BioPharm Brief: RNA Editing, Liver Safety, Joint Gains
Wave Life Sciences reported that its RNA‑editing candidate WVE‑006 achieved protein levels comparable to the milder MZ‑like phenotype in a Phase 1b/2a trial for alpha‑1 antitrypsin deficiency, suggesting a potential disease‑modifying effect. Novo Nordisk presented new semaglutide data from the ESSENCE...
AHA Recommends Changes to MACRA, Physician Payments to House Subcommittee
The American Hospital Association (AHA) submitted comments to the House Energy and Commerce Subcommittee urging updates to the Medicare physician fee schedule and reforms to the Medicare Access and CHIP Reauthorization Act (MACRA). The AHA asked Congress to adjust the...
Compare Medicare & ACA Plans with Medinsco
Medinsco announced a service to compare Medicare Advantage, Part D, and ACA health plans, offering free expert guidance and secure enrollment. The assistance is available to residents of Texas and extends nationwide. The promotion appeared on an AnandTech forum thread, which...
Wall Street Journal Publishes AHA Letter in Response to Anti-340B Editorial
The Wall Street Journal published a letter from American Hospital Association General Counsel Chad Golder responding to a May 7 editorial that criticized the 340B Drug Pricing Program. Golder argues the program lowers drug costs for patients, especially in rural areas,...
CDC Releases Advisory on Ebola Outbreak
The U.S. Centers for Disease Control and Prevention (CDC) issued a series of health advisories this year addressing Ebola outbreaks in the Democratic Republic of the Congo and Uganda, including a reminder for clinicians on patient evaluation and infection‑control practices....
AHA Podcast: The New Model Predicting Teen Mental Health Risks
Duke University researchers unveiled the Duke PMA, an AI‑driven model that predicts adolescent psychiatric risk by analyzing sleep patterns, device usage, and other lifestyle factors. The model leverages large‑scale biostatistical data to generate individualized risk scores for teens. Researchers highlighted...
Atyr Pharma Launches Global Phase 3 Trial C-006 of Efzofitimod for Pulmonary Sarcoidosis
Atyr Pharma announced the start of a global Phase 3 trial (C-006) of its anti‑inflammatory drug efzofitimod in pulmonary sarcoidosis, prioritizing forced vital capacity as the primary endpoint. The move follows a Type C meeting with the FDA that reshaped...
Surveillance: Post Drug-Approval Activities
The FDA’s Center for Drug Evaluation and Research (CDER) oversees post‑marketing surveillance to ensure that drugs remain safe and effective after approval. Through mandatory adverse‑event reporting and targeted monitoring programs, the agency can identify unexpected risks. When serious concerns arise,...
Fowler and Cannon Get It Right—And That’s the Easy Part
Economists Elizabeth Fowler and Michael Cannon argue that the tax exclusion for employer‑provided health insurance is the primary driver of rising U.S. health‑care spending. The exclusion foregoes about $478 billion in federal revenue this year and is projected to reach $749 billion...
Amplify Surgical and Emory Healthcare Perform First Continuously Navigated Endoscopic TLIF
Amplify Surgical and Emory Healthcare completed the world’s first continuously navigated endoscopic transforaminal lumbar interbody fusion (TLIF) using the dualPortal and dualX platforms. The procedure kept navigation active from skin incision through powered screw placement, a milestone for minimally invasive...
CorVel Q4 Profit Rises to $31M, Boosting Claims‑Management Outlook
CorVel Corp. reported fourth‑quarter profit of $31.0 million, up from $26.4 million a year earlier, and revenue of $248.5 million, a 7.4% increase. The results signal strong demand for the firm’s medical‑claims management and cost‑containment solutions among U.S. health insurers.
Guidance, Compliance, & Regulatory Information
The FDA’s Guidance, Compliance, & Regulatory Information hub aggregates key resources for drug manufacturers, ranging from compliance programs and inspection protocols to labeling and generic development guidance. Recent additions include an Environmental Impact Statement focused on sunscreen drug products and...
Eton Pharmaceuticals Secures U.S. Rights to IMPAVIDO, Adds 2026 Leishmaniasis Launch
Eton Pharmaceuticals announced an exclusive U.S. commercialization agreement for IMPAVIDO, the only FDA‑approved oral treatment for multiple forms of leishmaniasis, with rights effective Sept. 26, 2026. The deal adds a new 2026 launch to Eton’s rare‑disease pipeline and is tied to a...
Shockwave Medical's New IVL Catheter Overcomes Previous Limitations
Shockwave Medical unveiled an upgraded intravascular lithotripsy (IVL) catheter that adds a hydrophilic coating, a more flexible shaft, and a tapered tip, enabling easier navigation through tight, calcified lesions. The redesign also repositions lithotripsy emitters and cuts the pulse‑to‑pulse delay...
US Pediatric Mortality Rate Surpassed Peer Nations Decades Ago
A new study tracing U.S. child and adolescent all‑cause mortality back to 1935 shows the United States has lagged behind 13 peer OECD nations for more than five decades. While overall pediatric mortality fell 89 % in the U.S., the decline...
Women’s Body Temperature Rises From Age 18 to 42 but We Don’t Know Why
Researchers at SRI International analyzed temperature logs from a 1990s study of 750 women aged 18 to 42 and discovered a steady rise in resting body temperature of about 0.05 °C over that span. The increase occurs across both halves of...
Collaborative Drug Discovery Inks Deal with Eli Lilly to Accelerate Biotech Innovation
Eli Lilly’s TuneLab AI platform will be embedded into Collaborative Drug Discovery’s (CDD) Vault system, giving biotech companies access to Lilly’s proprietary ADMET predictive models. The integration will appear in both the core and AI modules of CDD Vault, allowing researchers...
How Civic Engagement Empowers Health Care Workers
Physicians are urging a shift beyond bedside care to active civic participation, arguing that health outcomes are deeply tied to policy decisions. Evidence links low voting rates to poorer health, and primary care settings can foster community empowerment. The Civic...
SMART Update: Self-Expanding TAVR Valves Still Linked to Superior Durability After 3 Years
New three‑year data from the SMART trial show that self‑expanding Evolut transcatheter aortic valve replacement (TAVR) valves outperform balloon‑expandable Sapien 3 devices in patients with small aortic annuli. The Evolut group experienced a bioprosthetic valve dysfunction rate of 16.3 % versus 54.4 %...
CMR Imaging, NT-proBNP Improve Risk Prediction in Hypertrophic Cardiomyopathy
A prospective registry of 2,698 hypertrophic cardiomyopathy (HCM) patients across 44 North American and European centers found that cardiac magnetic resonance (CMR) scar burden and the blood biomarker NT‑proBNP markedly improve long‑term risk prediction beyond current sudden cardiac death (SCD)...
Chronic Hand Eczema Linked to High Costs, Corticosteroid Overuse
A new real‑world claims analysis of 6,295 U.S. adults with moderate‑to‑severe chronic hand eczema (CHE) reveals pervasive reliance on systemic (86%) and topical (81%) corticosteroids, with only a fraction receiving immunosuppressants, monoclonal antibodies, or JAK inhibitors. Health‑care spending escalates sharply...
Contrast Use Significantly Increases Risk of Kidney Injury in Neonates
A retrospective study of neonates in intensive care from 2000 to 2023 found that iodinated contrast media (ICM) raises the incidence of acute kidney injury (AKI) to 13.9% compared with 8.2% in non‑contrast exams. AKI was defined by serum‑creatinine rises...
The Financial and Clinical Cost of Delayed MASH Detection and Fragmented Care
Metabolic dysfunction‑associated steatohepatitis (MASH) imposes a heavy financial burden, especially when diagnosis is delayed. Dr. Jaideep Behari highlighted that late detection accelerates progression to fibrosis, diabetes, chronic kidney disease and cardiovascular events, driving costly interventions such as liver transplantation. Early...
Research Finds Link Between Dopamine Antagonists, AMD
Researchers at Duke Health presented evidence that dopamine signaling influences age‑related macular degeneration (AMD). In a retrospective analysis of 558 eyes, patients on dopamine antagonists experienced a 27.3% conversion rate from dry to wet AMD, far higher than the 6.8%...
AI Scans Enable Decade‑long Primary Disease Prevention for High‑risk Patients
Using AI of a medical scan to achieve primary prevention of disease over the next decade in people at high-risk @ScienceTM https://t.co/inpvk55qBA https://t.co/3awSGlBjuK
Fujifilm and mTuitive Link Structured Pathology Reporting to Enterprise Imaging in New Partnership
Fujifilm Healthcare Americas and mTuitive have launched a partnership that links mTuitive’s CAP‑compliant synoptic pathology reporting platform directly to Fujifilm’s Synapse Pathology PACS. The integration streams structured pathology data—including biomarker and cancer registry fields—through the laboratory information system into the...
Medtronic to Buy SPR Therapeutics for About $650M
Medtronic announced a $650 million cash acquisition of SPR Therapeutics, a maker of a temporary peripheral nerve stimulation device for chronic pain. The Sprint system, cleared by the FDA in 2018, has logged 50,000 implants through 2025 and offers up to...
Ebola Is Spreading. Why Isn't America Responding?
A new Ebola outbreak of the Bundibugyo strain has erupted in Ituri Province, DRC, with 336 suspected cases and 87 deaths, including a cross‑border infection in Kampala. The United States has not deployed its former Disaster Assistance Response Team (DART)...
Who’s Training Your Doctor? A Wake-Up Call on Medical Education
In this episode, Dr. Jennifer Hibbard, a pediatric dental surgeon and faculty member at the University of Toronto, critiques the rapid shift toward simulated, AI‑driven medical education and the loosening of traditional entry requirements in Canadian health schools. She highlights...
FDA Offers New Details On Real-Time Clinical Trial Pilot, But Questions Remain
The FDA released new operational details for its real‑time clinical‑trial pilot, clarifying that raw patient‑level data will not be transmitted directly to the agency. Instead, sponsors must use their own data‑capture systems to send predefined safety, efficacy, dosing, or operational...
Approvals & Reports
The FDA has released a suite of public reports that detail its generic drug approval activities. These include the First Generic Drug Approvals list, Competitive Generic Therapy (CGT) approvals, and comprehensive activity metrics such as monthly and quarterly performance data....